scPharmaceuticals

YTD

ALL

Why Robinhood?

You can watch SCPH and buy or sell other stocks, ETFs, and their options commission-free!

About SCPH

scPharmaceuticals, Inc. engages in the development of transformative pharmaceutical products for subcutaneous delivery. The firm's products include FUROSCIX, a furosemide injection which is used as parenteral diuretic in treating heart failure.

CEO

Michael E. Castagna

CEOMichael E. Castagna

Employees

164

Employees164

Headquarters

Burlington, Massachusetts

HeadquartersBurlington, Massachusetts

Founded

2013

Founded2013

Employees

164

Employees164

SCPH Key Statistics

Market cap

302.16M

Market cap302.16M

Price-Earnings ratio

-3.13

Price-Earnings ratio-3.13

Dividend yield

—

Dividend yield—

Average volume

1.47M

Average volume1.47M

High today

—

High today—

Low today

—

Low today—

Open price

—

Open price—

Volume

0.00

Volume0.00

52 Week high

$6.15

52 Week high$6.15

52 Week low

$1.95

52 Week low$1.95

People also own

Based on the portfolios of people who own SCPH. This list is generated using Robinhood data, and it’s not a recommendation.